Bio-identical HRT
- 04 Dec 2023
- 1 Minute to read
- Print
- PDF
Bio-identical HRT
- Updated on 04 Dec 2023
- 1 Minute to read
- Print
- PDF
Article summary
Did you find this summary helpful?
Thank you for your feedback
- The use of compounded bioidentical HRT is not recommended due to safety concerns.
- Compounded bioidentical HRT is manufactured as creams, lozenges and vaginal preparations by ‘Specialist Pharmacies’.
- Some clinicians who prescribe compounded bio-identical HRT claim to be able to determine the precise requirements of each individual through a series of complex serum and saliva tests.
- This type of HRT has not been regulated by the MHRA, meaning there is a lack of rigorous safety testing, batch standardisation or purity measures.
- NICE says: Explain to people with menopause symptoms that the efficacy and safety of unregulated hormone preparations are unknown.
References and Further Information:
- NICE guideline. Menopause: diagnosis and management. Last updated December 2019. Section 1.4.15.
- National Institute for Health and Care Excellence. Guideline. Menopause (update). Draft for consultation, Nov 2023
- Joint position statement by the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on best practice recommendations for the care of women experiencing the menopause. Post Reproductive Health. 2022.
- Panay N. Bio-identical HRT BMS consensus statement. 2019.
Was this article helpful?